[go: up one dir, main page]

NO20065853L - Hydrogelinterferonformuleringer - Google Patents

Hydrogelinterferonformuleringer

Info

Publication number
NO20065853L
NO20065853L NO20065853A NO20065853A NO20065853L NO 20065853 L NO20065853 L NO 20065853L NO 20065853 A NO20065853 A NO 20065853A NO 20065853 A NO20065853 A NO 20065853A NO 20065853 L NO20065853 L NO 20065853L
Authority
NO
Norway
Prior art keywords
interferon
hydrogelinterferonformuleringer
relates
hydrogel formulations
sustained
Prior art date
Application number
NO20065853A
Other languages
Norwegian (no)
Inventor
Pierandrea Esposito
Maria Dorly Del Curto
Silvia Pompili
Ilaria Zambaldi
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2005/052219 external-priority patent/WO2005110466A1/en
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of NO20065853L publication Critical patent/NO20065853L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Den foreliggende oppfinnelse angår farmasøytiske Poloxamerhydrogelformuleringer som inneholder et interferon. Særlig angår oppflnnelsen hydrogelformuleringer av interferon-beta med opprettholdt frigjøring, fremgangsmåte til fremstilling og anvendelse derav.The present invention relates to pharmaceutical Poloxamer hydrogel formulations containing an interferon. In particular, the invention relates to sustained-release hydrogel formulations of interferon-beta, method of preparation and use thereof.

NO20065853A 2004-05-17 2006-12-15 Hydrogelinterferonformuleringer NO20065853L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04076496 2004-05-17
US57921804P 2004-06-14 2004-06-14
PCT/EP2005/052219 WO2005110466A1 (en) 2004-05-17 2005-05-13 Hydrogel interferon formulations

Publications (1)

Publication Number Publication Date
NO20065853L true NO20065853L (en) 2006-12-15

Family

ID=34969976

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065853A NO20065853L (en) 2004-05-17 2006-12-15 Hydrogelinterferonformuleringer

Country Status (3)

Country Link
IL (1) IL179208A0 (en)
MX (1) MXPA06013308A (en)
NO (1) NO20065853L (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118718772B (en) * 2024-07-03 2025-06-20 山东大学 A method for preparing a thin polyamide layer nanofiltration membrane based on thermosensitive hydrogel

Also Published As

Publication number Publication date
IL179208A0 (en) 2007-03-08
MXPA06013308A (en) 2007-02-02

Similar Documents

Publication Publication Date Title
EA200602137A1 (en) HYDROGEL PREPARATIONS OF INTERFERON
NO20063430L (en) Generally, rulers, effervescent oral fentanyl dosage form, and methods of administration
EP1513825A4 (en) ANTI-TUBERCULOUS DRUG: COMPOSITIONS AND METHODS
NO20062504L (en) Compositions and dosage forms for improved absorption
SE0301700D0 (en) Novel compounds
DK1478339T3 (en) Pharmaceutical formulations of antineoplastic agents, especially temozolomide, methods of preparation and use thereof
HUE040046T2 (en) Methods of administering pharmaceutical compositions and drugs
RS20120139A3 (en) 8- [3-AMINO-PYRIDIN-1-IL] -XANTINE, THEIR PREPARATION AND THEIR APPLICATION AS PHARMACEUTICAL COMPOSITIONS
DK1490062T3 (en) Glucocorticoid mimetics, methods for their preparation, pharmaceutical compositions and uses thereof
ATE302616T1 (en) MEDICINAL COMPOSITIONS FOR ORAL APPLICATION WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS
TW200505875A (en) Novel compounds
CY1111470T1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLYVERSERIN POLYMORPH A
ATE470443T1 (en) INDOL-1-YL ACID DERIVATIVES
CY1118179T1 (en) PHARMACEUTICAL COMPOSITION
NO20065860L (en) Stabilized liquid interferon formulations
EA200501821A1 (en) PHARMACEUTICAL COMBINATION, CONTAINING MODAFINIL AND OTHER DRUG PREPARATION
DK1771155T3 (en) Method and composition for the treatment of rhinitis
ITRM20030363A1 (en) COMPOSITIONS INCLUDING 3THIODOTYRONIN AND PHARMACEUTICAL USE OF THEM.
MEP34308A (en) Oral formulations of cladribine
DK1520587T3 (en) Allergy vaccine composition, method of preparation thereof and use thereof for allergy treatment
HRP20050633A2 (en) Formulation and methods for the treatment of thrombocythemia
IS7424A (en) Oxazolidinone derivatives, methods of preparing them and pharmaceutical compositions containing them
NO20062605L (en) Pharmaceutical formulation containing flavoring substances with improved pharmaceutical properties
DK1696913T3 (en) Vinflunin-containing pharmaceutical composition for parenteral administration, method of preparation thereof and its use
NO20076120L (en) Stable nanoparticle formulations

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application